- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05929469
PATH to Health: An Exploration of Digital Behavioral Weight Loss Approaches
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27514
- University of North Carolina at Chapel Hill
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Current age: 18-65 years
- Lives in North Carolina
- Body mass index (BMI) of 27.5-45 kg/m^2
- Ability to read, write, and speak English
- Ownership of iPhone with a data and texting plan
- Ability to commit to the required counseling sessions (0-5 sessions, based on randomization)
- Is not living a participant or staff member on this trial
- Willingness to be randomized to any of the treatment sequences
Exclusion Criteria:
- Weight loss of more than 10 pounds in the last 6 months that was maintained
- A history of weight loss surgery
- Pre-existing medical condition(s) that prevent them from adhering to a supervised exercise routine
- Have Type 1 Diabetes or are currently taking medicine for Type 2 Diabetes
- Have recently been diagnosed or treated for cancer
- Currently pregnant, pregnant within the past 6 months, or plan to become pregnant in the next 6 months
- Report taking prescription or over the counter medication with a known impact on metabolism or weight
- Report a history of an eating disorder
- History of psychotic disorder or bipolar disorder, or have been hospitalized for depression or other psychiatric disorder within the past 12 months
- History of alcohol or substance abuse
- Current participation in another weight loss program that may interfere with participation in this study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Fully Automated Kick-Off + App
This arm includes participants who respond to the Fully Automated Kick-Off + App in stage 1. In stage 1, participants will receive a Fully Automated Kick-Off and an mHealth program. In stage 2, responders to the Fully Automated Kick-Off + App will continue with the mHealth program, alone, for the remainder of the study. |
Participants will receive an mHealth program.
As an orientation to the study, participants will receive a fully automated kick-off session.
|
|
Experimental: Human-Enhanced Kick-Off + App
This arm includes participants who respond to the Human-Enhanced Kick-Off + App in stage 1. In stage 1, the participant's kick-off will include a session with a study interventionist. They will also receive an mHealth program. In stage 2, responders to the Human-Enhanced Kick-Off + App will continue with the mHealth program, alone, for the remainder of the study. |
Participants will receive an mHealth program.
As an orientation to the study, participants will receive a kick-off session that includes time with a study interventionist.
|
|
Experimental: Fully Automated Kick-Off + App + Check-In
This arm includes participants who do not respond to the Fully Automated Kick-Off + App in stage 1. In stage 1, participants will receive a Fully Automated Kick-Off and an mHealth program. In stage 2, they will continue with the mHealth program, but will also receive a check-in with a study interventionist. |
Participants will receive an mHealth program.
As an orientation to the study, participants will receive a fully automated kick-off session.
Participants will receive a check-in with a study interventionist.
|
|
Experimental: Fully Automated Kick-Off + App + Counseling
This arm includes participants who do not respond to the Fully Automated Kick-Off + App in stage 1. In stage 1, participants will receive a Fully Automated Kick-Off and an mHealth program. In stage 2, they will continue with the standard mHealth program, but will also receive counseling from a study interventionist. |
Participants will receive an mHealth program.
As an orientation to the study, participants will receive a fully automated kick-off session.
Participants will receive counseling from a study interventionist.
|
|
Experimental: Human-Enhanced Kick-Off + App + Check-In
This arm includes participants who do not respond to the Human-Enhanced Kick-Off + App in stage 1. In stage 1, the participant's kick-off will include a session with a study interventionist. They will also receive an mHealth program. In stage 2, they will continue with the mHealth program, but will also receive a check-in with a study interventionist. |
Participants will receive an mHealth program.
As an orientation to the study, participants will receive a kick-off session that includes time with a study interventionist.
Participants will receive a check-in with a study interventionist.
|
|
Experimental: Human-Enhanced Kick-Off + App + Counseling
This arm includes participants who do not respond to the Human-Enhanced Kick-Off + App in stage 1. In stage 1, the participant's kick-off will include a session with a study interventionist. They will also receive an mHealth program. In stage 2, they will continue with the standard mHealth program, but will also receive counseling from a study interventionist. |
Participants will receive an mHealth program.
As an orientation to the study, participants will receive a kick-off session that includes time with a study interventionist.
Participants will receive counseling from a study interventionist.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility- Rate of early nonresponse
Time Frame: 4 weeks
|
The rate of early response will be calculated as the number of individuals deemed "early responders" divided by the total number of participants randomized.
|
4 weeks
|
|
Feasibility- Percentage of participants with missing data at 4 weeks
Time Frame: 4 weeks
|
The percentage of participants with missing data at 4 weeks will be calculated as the number of participants who do not complete the 4-week weight assessment divided by the total number of participants randomized.
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight Change- Percent weight change from baseline to 3 months
Time Frame: Baseline, 3 months
|
Percent weight change from baseline to 3 months will be calculated ((3 month weight - baseline weight)/100).
Weight will be objectively measured on a scale in the participant's home.
|
Baseline, 3 months
|
|
Weight Change- Percent weight change from baseline to 4 weeks
Time Frame: Baseline, 4 weeks
|
Percent weight change from baseline to 4 weeks will be calculated ((4 week weight - baseline weight)/100).
Weight will be objectively measured on a scale in the participant's home
|
Baseline, 4 weeks
|
|
Weight Change- Percent weight change from 4 weeks to 3 months
Time Frame: 4 weeks, 3 months
|
Percent weight change from 4 weeks to 3 months will be calculated ((3 month weight - 4 week weight)/100).
Weight will be objectively measured on a scale in the participant's home
|
4 weeks, 3 months
|
|
Acceptability- Rate of attendance at human support sessions
Time Frame: Up to 3 months
|
The rate of attendance at human support sessions will be calculated as the number of human sessions completed divided by the number of human sessions assigned.
|
Up to 3 months
|
|
Acceptability- Overall program satisfaction rating
Time Frame: 3 months
|
Overall program satisfaction will be assessed using a single item, which asks participants to rate their overall satisfaction with the program on a 4-point Likert scale that ranges from "very dissatisfied" to "very satisfied," in which higher scores indicate greater levels of satisfaction.
|
3 months
|
|
Weighing Self-Monitoring Adherence
Time Frame: Baseline to 3 months (daily)
|
Number of days of self-weighing over the 3 month period, measured by use of the scale in the participant's home.
|
Baseline to 3 months (daily)
|
|
Dietary Self-Monitoring Adherence
Time Frame: Baseline to 3 months (daily)
|
Number of days of complete dietary tracking summed over the 3-month study period, as measured by app use data.
|
Baseline to 3 months (daily)
|
|
Physical Activity Self-Monitoring Adherence
Time Frame: Baseline to 3 months (daily)
|
Number of days of physical activity tracking over the 3 month period, as measured by Fitbit tracker wear.
|
Baseline to 3 months (daily)
|
|
Dietary Goal Adherence
Time Frame: Baseline to 3 months (daily)
|
Number of days the participant met their daily calorie goal over the 3 month period, as measured by app data.
|
Baseline to 3 months (daily)
|
|
Activity Goal Adherence
Time Frame: Baseline to 3 months (daily)
|
Number of days the participant met their active minutes goal over the 3 month period, as measured by app data.
|
Baseline to 3 months (daily)
|
|
Change in Physical Activity
Time Frame: Baseline, 3 months
|
Change in physical activity from baseline to 3 months, as measured using the Paffenbarger Physical Activity Questionnaire (PPAQ).
The PPAQ assesses amount of planned and lifestyle associated physical activity performed during a typical week.
The PPAQ consists of three components: (1) stair climbing, (2) walking, and (3) sports and recreation.
Participants report the frequency and duration of physical activity in the past week.
Scoring yields energy expenditure from physical activity per week (kcal/kg/week).
Higher scores translate into greater energy expenditure per week (i.e.,better outcome).
Range is 0 - no theoretical maximum.
|
Baseline, 3 months
|
|
Change in Motivation
Time Frame: Baseline, 1 week, 4 weeks, 3 months
|
Change in motivation from baseline to 4 weeks and 3 months, as measured using the Treatment Self-Regulation Questionnaire (TSRQ).
The TSRQ assesses autonomous and controlled motivation for weight management.
Six items assess autonomous motivation and six assess controlled motivation using a 7 point Likert scale, in which 1 corresponds to "not at all true" and 7 corresponds to "very true."
Items will be averaged to produce scores for autonomous motivation and controlled motivation ranging from 1-7.
Higher values on each sub-scale indicate greater levels of that type of motivation.
A Relative Autonomous Index (RAI) score will be separately calculated by subtracting the controlled motivation score from the autonomous motivation score.
The range of possible RAI scores is -6 to 6.
|
Baseline, 1 week, 4 weeks, 3 months
|
|
Change in Diet
Time Frame: Baseline, 3 months
|
Change in daily caloric intake from baseline to 3 months, as measured using the self- administered National Cancer Institute's Automated Self- Administered 24-hour Recall (ASA-24), a 24-hour recall that is self-administered on one day at each timepoint.
|
Baseline, 3 months
|
|
Acceptability- Attrition
Time Frame: Up to 3 months
|
Attrition will be calculated as the number of intervention participants who did not complete 3-month weight measures divided by the number randomized to treatment.
|
Up to 3 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Caitlin Martinez, MS, RD, University of North Carolina, Chapel Hill
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 23-0396
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on App
-
University of VictoriaRecruiting
-
Hypnalgesics, LLCTufts UniversityCompletedDental Anxiety | Opioid Use | Drug Use | Dental PainUnited States
-
Barbara Ann Karmanos Cancer InstituteCompletedCancer | Financial Toxicity | Question Prompt ListUnited States
-
Chang Gung UniversityChang Gung Memorial HospitalRecruiting
-
The University of Hong KongNot yet recruitingDigital Health | Knee Pain/OsteoarthritisHong Kong
-
University of California, San FranciscoConquer Cancer FoundationCompletedProstate Cancer | Metastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
Institute for Human Development and Potential (IHDP)...Active, not recruitingType 2 Diabetes | Gestational Diabetes | Healthy Lifestyle BehaviorsSingapore
-
Big Health Inc.National Institute of Mental Health (NIMH); Duke UniversityActive, not recruiting
-
University Hospitals Cleveland Medical CenterCompleted
-
New York UniversityJoon, Inc.RecruitingDepression | Stress | Anxiety | Executive Dysfunction | Behavior, Child | Disruptive Behavior | Attention-deficitUnited States